Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
ASSETS    
Cash and cash equivalents (Note 2) $ 3,897 $ 441
Marketable securities, available for sale 23,641
Escrow receivable, current 2,500
Accounts receivable, net (Note 2) 1,113 5,770
Inventory (Note 2) 1,992 2,736
Prepaid expenses and other current assets (Note 2) 568 680
Assets held for sale (Note 3) 22
Total current assets 33,733 9,627
Property, plant and equipment, net of accumulated depreciation of $5,369 and $5,134, respectively (Note 2) 2,849 3,175
Escrow receivable 2,500
Total assets 39,082 12,802
LIABILITIES    
Secured promissory notes, net (Note 4) 1,490
Accounts payable 503 2,156
Accrued advertising and other allowances (Note 2) 1,288 2,805
Other current liabilities 322 389
Due to Mylan, Inc. and affiliates (Note 3) 319
Total current liabilities 2,432 6,840
COMMITMENTS AND CONTINGENCIES (Note 7)
STOCKHOLDERS' EQUITY    
Preferred stock, authorized 1,000,000, $.0005 par value, no shares issued (Note 5)
Common stock, $.0005 par value; authorized 50,000,000; issued: 27,046,593 and 26,313,593 shares, respectively (Note 5) 13 13
Additional paid-in-capital 57,347 56,378
Retained earnings (Accumulated deficit) 21,869 (19,687)
Accumulated comprehensive loss (35)
Treasury stock, at cost, 14,618,132 and 9,232,817 shares (Note 5) (42,544) (30,742)
Total stockholders' equity 36,650 5,962
Total liabilities and stockholders' equity $ 39,082 $ 12,802